未登录 返回 期刊详情
期刊论文 32 相关解读 0
Chinese Society of Clinical Oncology breast cancer expert consensus on the diagnosis and treatment of breast cancer brain metastasis (2025) 中国临床肿瘤学会乳腺癌脑转移诊断和治疗专家共识(2025) Wang, Tao; Chen, Jiayi; Yang, Jin; Fu, Minjie; Hua, Wei; Jia, Wang; Liu, Yueping; Wang, Biyun; Yan, Min; Hao, Chunfang; Chen, Jiaxin; Ou, Dan; Song, Erwei; Jiang, Tao; Mao, Ying; Jiang, Zefei 分享 收藏
Clinical practice guidelines for prognosis and follow-up of early-stage breast cancer patients: Chinese Society of Breast Surgery (CSBrS) practice guidelines (2026 edition) Chinese Society of Breast Surgery, Chinese Society of Surgery, Chinese Medical Association 早期乳腺癌患者预后与随访的临床实践指南:中国 Breast Surgery 学会(CSBrS)实践指南(2026年版)中国 Breast Surgery 学会,中国外科学会,中国医学协会 Wang, Jia; Zhang, Dianlong; Zhang, Yuting; Wu, Nan; Yu, Hao; Guan, Yufu; Fan, Zhimin; Liu, Yinhua; Jin, Feng 分享 收藏
Chemotherapy-induced peripheral neuropathy in breast cancer: a narrative review Brodsky, M.; Lalla, M.; Oh, S.; Anampa, J.D. 化疗诱导的周围神经病变在乳腺癌中的表现:一篇叙事性综述. Transl. Breast Cancer Res. 2026, 7, 18. [Google Scholar] [CrossRef] [PubMed] Brodsky, Michael; Lalla, Mumtu; Oh, Sun; Anampa, Jesus D. 分享 收藏
Datopotamab deruxtecan in Chinese patients with heavily pretreated advanced or metastatic triple-negative breast cancer in the phase I/II TROPION-PanTumor02 study 达波妥昔单抗德鲁替康在中国重度预治晚期或转移性三阴性乳腺癌患者中的I/II期TROPION-PanTumor02研究 Wang, Tao; Sun, Yuping; Chen, Wenyan; Li, Wei; Cheng, Jing; Li, Man; Yuan, Zhongyu; Qian, Jun; Wang, Kun; Wang, Shu; Xiong, Huihua; Yu, Zhigang; Wang, Xiaojia; Wu, Chunjiao; Maxwell, Micah J.; Zhang, Biao; Liu, Chang; Zeng, Xiaoling; Jiang, Zefei 分享 收藏
Prognostic value of RecurIndex in differentiating HER2-low from HER2-negative early-stage breast cancer: a comprehensive clinicopathologic and molecular analysis in Chinese patients RecurIndex在区分HER2-low与HER2-阴性早期乳腺癌中的预后价值:一项针对中国患者的全面临床病理及分子分析 Zhang, Shuo; Hui, Tianli; Gao, Wei; Shi, Jiajie; Cheng, Meng; Wang, Mengxiao; Chen, Dongsheng; Zhang, Xing; Tan, Yuan; Geng, Cuizhi 分享 收藏
BRCA and CDK4/6: allies or antagonists?-efficacy of CDK4/6 inhibitors in HR+/HER2-breast cancer with germline BRCA1/2 mutations: a narrative review BRCA和CDK4/6:盟友还是对手?——携带胚系BRCA1/2突变的HR+/HER2-乳腺癌中CDK4/6抑制剂的疗效:一项叙述性综述 Illia, Maria Florencia; Colucci, Giuliana; Mignola, Andres Rodriguez; Eiben, Mariana; Ballester, Angeles Maria; Zeff, Natalia; Paesani, Fernando; Crimi, Gabriel; Von Stecher, Francisco; de la Vega, Maximo; Perazzo, Florencia; Mando, Pablo 分享 收藏
Real-world efficacy and prognostic factors of CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer: a multicenter retrospective study from the Dongting Lake region of China CDK4/6抑制剂在HR+/HER2-转移性乳腺癌中的真实世界疗效及预后因素:一项来自中国洞庭湖区域的多中心回顾性研究 Liu, Binliang; Wu, Tao; Lu, Kaili; Chen, Jun; Zhou, Qiang; Liu, Liping; Tian, Can; Hu, Zhe-Yu; Tang, Yu; Ouyang, Quchang; Xie, Ning 分享 收藏
Chinese expert consensus on endocrine therapy for breast cancer (2026 edition) 乳腺癌内分泌治疗中国专家共识(2026年版) Yuan, Yang; Yin, Yongmei; Wang, Shu; Liu, Yueping; Yang, Jin; Yan, Min; Mo, Xueli; Pan, Yueyin; Wang, Xiaojia; Wang, Haibo; Li, Jianbin; Wang, Shusen; Wu, Jiong; Song, Erwei; Jiang, Zefei 分享 收藏